Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

2.

Antiplatelet and anticoagulation for patients with prosthetic heart valves.

Little SH, Massel DR.

Cochrane Database Syst Rev. 2003;(4):CD003464. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD003464.

PMID:
14583979
3.

Antiplatelet and anticoagulation for patients with prosthetic heart valves.

Massel DR, Little SH.

Cochrane Database Syst Rev. 2013 Jul 9;(7):CD003464. doi: 10.1002/14651858.CD003464.pub2. Review.

PMID:
23839768
4.
5.

[EBM of cerebral infarction: message from mega-studies].

Uchiyama S.

Rinsho Shinkeigaku. 2003 Nov;43(11):884-6. Review. Japanese.

PMID:
15152493
6.

Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.

Crown N, Mysak T.

Am J Health Syst Pharm. 2010 May 1;67(9):728-33. doi: 10.2146/ajhp080645. Review.

PMID:
20410547
7.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137
8.
9.

Oral anticoagulant treatment with and without aspirin.

Altman R, Rouvier J, Gurfinkel E.

Thromb Haemost. 1995 Jul;74(1):506-10. Review.

PMID:
8578514
10.
11.
12.

Antiplatelet therapy in anticoagulated patients requiring coronary intervention.

Arab D, Lewis B, Cho L, Steen L, Joyal D, Leya F.

J Invasive Cardiol. 2005 Oct;17(10):549-54. Review.

PMID:
16204751
13.

Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.

Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX.

Int J Cardiol. 2011 Apr 1;148(1):96-101. doi: 10.1016/j.ijcard.2010.11.019. Epub 2010 Dec 23. Review.

PMID:
21185095
14.

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.

Andreotti F, Testa L, Biondi-Zoccai GG, Crea F.

Eur Heart J. 2006 Mar;27(5):519-26. Epub 2005 Sep 5. Review.

PMID:
16143706
15.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315
16.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

17.

Prevention of vascular events in patients with atrial fibrillation: evidence, guidelines, and practice.

Connolly SJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S52-5. Review.

PMID:
12950519
18.

Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?

Usman MH, Notaro LA, Nagarakanti R, Brahin E, Dessain S, Gracely E, Ezekowitz MD.

Am J Cardiol. 2009 Apr 15;103(8):1107-12. doi: 10.1016/j.amjcard.2009.01.003. Epub 2009 Mar 4. Review.

PMID:
19361598
19.
20.

Treating the non-electrical risks of atrial fibrillation.

Gershlick AH.

Eur Heart J. 1997 May;18 Suppl C:C19-26. Review.

PMID:
9152671

Supplemental Content

Support Center